Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 7638736)

1.

Alterations of the interleukin-4 pathway in production of tolerance by mixed hematopoietic chimerism.

Orloff MS, DeMara EM, Coppage ML, Leong N, Zuo XJ, Prehn J, Jordan SC.

Surgery. 1995 Aug;118(2):212-9.

PMID:
7638736
2.

Abstract 104: MHC class I sharing influences the fate of the epidermal component of vascularized composite allografts in mixed chimerism based tolerance protocols in miniature Swine.

Shanmugarajah K, Mallard C, Leonard DA, Albritton A, Powell H, Harrington E, Randolph MA, Sachs DH, Kurtz JM, Cetrulo CL Jr.

Plast Reconstr Surg. 2014 Mar;133(3 Suppl):119. doi: 10.1097/01.prs.0000444928.61077.5d. No abstract available.

PMID:
25942215
3.
4.

Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.

Mathes DW, Hwang B, Graves SS, Edwards J, Chang J, Storer BE, Butts-Miwongtum T, Sale GE, Nash RA, Storb R.

Transplantation. 2011 Dec 27;92(12):1301-8. doi: 10.1097/TP.0b013e318237d6d4.

5.

Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.

Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.

J Surg Res. 2008 May 15;146(2):289-97. doi: 10.1016/j.jss.2007.07.017. Epub 2007 Aug 23.

PMID:
18314139
6.

Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.

Plain KM, Boyd R, Verma ND, Robinson CM, Tran GT, Hodgkinson SJ, Hall BM.

Transplantation. 2007 Mar 27;83(6):764-73.

PMID:
17414711
7.

Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.

Itakura S, Asari S, Rawson J, Ito T, Todorov I, Liu CP, Sasaki N, Kandeel F, Mullen Y.

Am J Transplant. 2007 Feb;7(2):336-46.

PMID:
17283484
8.

Role of thymus in operational tolerance induction in limb allograft transplant model.

Siemionow M, Izycki D, Ozer K, Ozmen S, Klimczak A.

Transplantation. 2006 Jun 15;81(11):1568-76.

PMID:
16770246
9.

Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.

Okayama J, Ko S, Kanehiro H, Kanokogi H, Nakajima Y.

J Surg Res. 2006 Jun 15;133(2):61-8. Epub 2005 Dec 27.

PMID:
16376943
10.

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.

Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.

Transplant Proc. 2005 Mar;37(2):737-42.

PMID:
15848518
11.
12.

Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.

Yang YG.

Springer Semin Immunopathol. 2004 Nov;26(1-2):187-200. Epub 2004 Sep 11. Review.

PMID:
15378269
13.

Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.

Okayama J, Ko S, Kanehiro H, Kanokogi H, Hisanaga M, Ohashi K, Sho M, Nagao M, Ikeda N, Kanamura T, Akashi S, Nakajima Y.

J Surg Res. 2004 Jul;120(1):102-10.

PMID:
15172196
14.

Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine.

Hettiaratchy S, Melendy E, Randolph MA, Coburn RC, Neville DM Jr, Sachs DH, Huang CA, Lee WP.

Transplantation. 2004 Feb 27;77(4):514-21.

PMID:
15084927
15.

Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness.

Inverardi L, Linetsky E, Pileggi A, Molano RD, Serafini A, Paganelli G, Ricordi C.

Transplantation. 2004 Mar 15;77(5):647-55.

PMID:
15021823
17.

Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.

Bartlett AS, McCall JL, Ameratunga R, Howden B, Ramadas R, Yeong ML, Benjamin CD, Hess D, Munn SR.

J Surg Res. 2003 Nov;115(1):1-8.

PMID:
14572766
18.

Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.

Nakao A, Nalesnik MA, Ishikawa T, Azhipa O, Demetris AJ, Murase N.

Transplantation. 2003 May 15;75(9):1575-81.

PMID:
12792518
19.

Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.

van Pel M, Hilbrands L, Smits D, van Breugel DW, van Eck M, Boog CJ.

Transpl Immunol. 2003 Jan-Mar;11(1):57-63.

PMID:
12727476
20.

Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.

Gorantla VS, Prabhune KA, Perez-Abadia G, Ildstad ST, Maldonado C, Orhun HI, Majzoub RK, Francois CG, Kakoulidis TP, Brouha PC, Anderson GL, Pidwell DJ, Breidenbach WC, Barker JH.

Transplantation. 2003 Apr 15;75(7):922-32.

PMID:
12698075
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk